Literature DB >> 17436386

K-ras and Dpc4 mutations in chronic pancreatitis: case series.

Marijana Popović Hadzija1, Marina Korolija, Jasminka Jakić Razumović, Pajica Pavković, Mirko Hadzija, Sanja Kapitanović.   

Abstract

AIM: To assess whether alterations in the K-ras, p53, and DPC4 genes are present in pancreatitis, a potential precancerous condition that can progress to pancreatic adenocarcinoma. To investigate the alterations occurring at hot spots of K-ras (exon 1), p53 (exons 5 and 7), and DPC4 (exons 8, 10 and 11).
METHODS: In 10 patients with acute and 22 with chronic pancreatitis, without pancreatic intraepithelial neoplasia (PanIN), DNA was isolated from paraffin embedded tissue samples. The extracted DNA was analyzed by polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP) analysis, single-strand conformation polymorphism (SSCP) analysis, and DNA sequencing.
RESULTS: In acute pancreatitis samples no mutations were found in any of the investigated genes. In 7 out of 22 samples of chronic pancreatitis nucleotide substitution at exon 1 of K-ras (five at codon 12 and two at codon 13) were found. No mutations in p53 (exons 5 and 7) were detected. Two samples had nucleotide substitutions at exons 8 and 11 of DPC4, introducing STOP signal and change in the amino acid sequence, respectively. One chronic pancreatitis sample displayed simultaneous mutations in K-ras (exon 1, codon 12) and DPC4 (exon 8, codon 358).
CONCLUSION: Mutations of K-ras and Dpc4 genes can accumulate already in non-malignant, inflammatory pancreatic tissue, suggesting its applicability in monitoring of further destruction of pancreatic tissue and progression into malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436386      PMCID: PMC2080529     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  34 in total

Review 1.  Germline mutations and gene polymorphism associated with human pancreatitis.

Authors:  F Ulrich Weiss; Peter Simon; Julia Mayerle; Matthias Kraft; Markus M Lerch
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

Review 2.  Acute pancreatitis: assessment of severity with clinical and CT evaluation.

Authors:  Emil J Balthazar
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

3.  Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowskal; Janusz Strzelczyk; Adam Janiak; Ewa Malecka-Panas
Journal:  Hepatogastroenterology       Date:  2006 Jul-Aug

4.  Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.

Authors:  H Inoue; T Furukawa; M Sunamura; K Takeda; S Matsuno; A Horii
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

5.  Chronic pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2004-09       Impact factor: 3.287

6.  Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.

Authors:  P E Queneau; G L Adessi; P Thibault; D Cléau; B Heyd; G Mantion; P Carayon
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.

Authors:  M Arvanitakis; J-L Van Laethem; J Parma; V De Maertelaer; M Delhaye; J Devière
Journal:  Endoscopy       Date:  2004-06       Impact factor: 10.093

8.  Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.

Authors:  Christine A Iacobuzio-Donahue; Jason Song; Giovanni Parmiagiani; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

9.  Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases.

Authors:  Lydie Costentin; Philippe Pagès; Michèle Bouisson; Philippe Berthelémy; Louis Buscail; Jean Escourrou; Lucien Pradayrol; Nicole Vaysse
Journal:  Pancreatology       Date:  2002       Impact factor: 3.996

10.  Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinoma.

Authors:  B V Kallakury; T A Jennings; J S Ross; K Breese; H L Figge; H A Fisher; J Figge
Journal:  Diagn Mol Pathol       Date:  1994-12
View more
  7 in total

Review 1.  PAR-4 as a possible new target for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; Syed F Zafar; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

2.  Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.

Authors:  Sujuan Yang; Sara P Y Che; Paul Kurywchak; Jena L Tavormina; Liv B Gansmo; Pedro Correa de Sampaio; Michael Tachezy; Maximilian Bockhorn; Florian Gebauer; Amanda R Haltom; Sonia A Melo; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Biol Ther       Date:  2017-01-25       Impact factor: 4.742

3.  Toward a fluorescent single-strand conformation polymorphism technique that detects all mutations: F-DOVAM-S.

Authors:  Cameron Mroske; John Muci; Jicheng Wang; Kai Li; Wenjia Song; Jin Yan; Jinong Feng; Qiang Liu; Steve S Sommer
Journal:  Anal Biochem       Date:  2007-05-26       Impact factor: 3.365

Review 4.  Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.

Authors:  Mami Takahashi; Michihiro Mutoh; Rikako Ishigamori; Gen Fujii; Toshio Imai
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

5.  Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer.

Authors:  Suprit Gupta; Avi Prajapati; Mansi Gulati; Shailendra K Gautam; Sushil Kumar; Vipin Dalal; Geoffrey A Talmon; Satyanarayana Rachagani; Maneesh Jain
Journal:  Neoplasia       Date:  2020-01-07       Impact factor: 5.715

6.  Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis.

Authors:  Robert W Cowan; Erica D Pratt; Jin Muk Kang; Jun Zhao; Joshua J Wilhelm; Muhamad Abdulla; Edmund M Qiao; Luke P Brennan; Peter J Ulintz; Melena D Bellin; Andrew D Rhim
Journal:  Clin Transl Gastroenterol       Date:  2021-11-18       Impact factor: 4.488

7.  A case of synchronous double primary breast carcinoma and osteosarcoma: Mismatch repair genes mutations as a possible cause for multiple early onset malignant tumors.

Authors:  Hytham Ahmed; Asmaa Salama; Salem Eid Salem; Abeer A Bahnassy
Journal:  Am J Case Rep       Date:  2012-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.